Under construction – not a live service
Sign in
Not yet taking people in CzechiaNo phase

Skin Glue Versus Stitch to Close Groin Vein Punctures After Heart Rhythm Procedures

Compares skin glue with a stitch for groin vein closure.

Plain-language title generated from the registry record
Registry title: Tissue Adhesive Versus Figure-of-Eight Suture for Femoral Venous Closure After Electrophysiology Procedures (GLUE-EP)

Key facts

Where
Třinec, CzechiaSee the site

Where in Czechia

  • Nemocnice AGEL Třinec-Podlesí a.s.Třinec, CzechiaNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Nemocnice AGEL Trinec-Podlesi a.s.
Trial code
NCT07926191
Record updated
9 November 2026
Original description
In July 2026 the electrophysiology laboratory of a Czech tertiary cardiology centre introduced topical cyanoacrylate tissue adhesive (DERMABOND Mini or Histoacryl) as a routine alternative to the figure-of-eight suture for closing femoral venous puncture sites after electrophysiology procedures, including pulsed-field ablation performed through 13-17 F sheaths. After sheath removal, haemostasis is achieved by manual compression and the adhesive seals the skin over the puncture. The change was a clinical decision of the department, not a study intervention.Read full original descriptionShow less

Topical Cyanoacrylate Tissue Adhesive Versus Figure-of-Eight Suture for Closure of Femoral Venous Access After Electrophysiology Procedures, Including Large-Bore Pulsed-Field Ablation: a Single-Centre Retrospective Cohort Study With Prospective Continuation (GLUE-EP)

In July 2026 the electrophysiology laboratory of a Czech tertiary cardiology centre introduced topical cyanoacrylate tissue adhesive (DERMABOND Mini or Histoacryl) as a routine alternative to the figure-of-eight suture for closing femoral venous puncture sites after electrophysiology procedures, including pulsed-field ablation performed through 13-17 F sheaths. After sheath removal, haemostasis is achieved by manual compression and the adhesive seals the skin over the puncture. The change was a clinical decision of the department, not a study intervention.

Published experience with this approach is limited, particularly for large-bore venous sheaths. GLUE-EP evaluates the access-site safety of the practice change using routinely recorded data only. Procedures closed with tissue adhesive are compared with a historical cohort closed with a figure-of-eight suture in 2024-2025 (propensity-score matched) and with a concurrent cohort closed with a suture during the same period. A prospective continuation collects the same routine data until 30 June 2027 from patients who give written informed consent.

The study assigns no treatment, adds no examination, questionnaire or study visit, and does not influence how the puncture site is closed. The primary outcome is any major or minor access-site vascular complication within 30 days of the procedure.

Inclusion: Age 18 years or older; Elective electrophysiology procedure (diagnostic study or catheter ablation) with at least one femoral venous sheath; Femoral venous puncture site closed with topical cyanoacrylate tissue adhesive (Groups A and P) or with a figure-of-eight suture (Groups B and C); Group P only: written informed consent to the use of routine medical records.

Exclusion: Arterial access during the same procedure; Non-elective or emergency procedure; Groups B and C: documentation of a closure method other than a figure-of-eight suture (compression alone, vascular closure device); Group P only: inability to understand the patient information or to give consent.

ClinicalTrials.gov NCT07926191